NEDA epoch analysis of patients with relapsing multiple sclerosis treated with ocrelizumab: Results from OPERA I and OPERA II, phase III studies.

被引：0

作者：

Giovannoni, G. ^{[1
]}

Arnold, D. L. ^{[2
,3
]}

Bar-Or, A. ^{[2
]}

Comi, G. ^{[4
]}

Hartung, H. -P. ^{[5
]}

Havrdova, E. ^{[6
]}

Kappos, L. ^{[7
]}

Lublin, F. ^{[8
]}

Selmaj, K. ^{[9
]}

Traboulsee, A. ^{[10
]}

Belachew, S. ^{[11
]}

Han, J. ^{[12
]}

Julian, L. ^{[12
]}

Hauser, S. L. ^{[13
]}

机构：

[1] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London, England

[2] McGill Univ, Montreal, PQ, Canada

[3] NeuroRx Res, Montreal, PQ, Canada

[4] Univ Vita Salute San Raffaele, Milan, Italy

[5] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

[6] Charles Univ Prague, Prague, Czech Republic

[7] Univ Basel Hosp, Basel, Switzerland

[8] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[9] Med Univ Lodz, Lodz, Poland

[10] Univ British Columbia, Vancouver, BC, Canada

[11] F Hoffmann La Roche Ltd, Basel, Switzerland

[12] Genentech Inc, San Francisco, CA 94080 USA

[13] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1593

引用

页码：837 / 838

页数：2